Bioinformatics and Population Sciences
Saro Armenian, D.O., M.P.H.
Dr. Armenian, Professor at the Department of Pediatrics and Population Sciences, is the Director of Childhood Cancer Survivorship Clinic. Dr. Armenian’s research focuses on understanding the effect of childhood cancer on cardiovascular disease and on developing strategies for cardiovascular screening of cancer survivors.
Dr. Armenian, Professor at the Department of Pediatrics and Population Sciences, is the Director of Childhood Cancer Survivorship Clinic. Dr. Armenian’s research focuses on understanding the effect of childhood cancer on cardiovascular disease and on developing strategies for cardiovascular screening of cancer survivors.
Kimlin Tam Ashing, Ph.D.
Dr. Ashing, Professor at the Department of Population Sciences, is the Deputy Director of the Division of Health Equities, Associate Cancer Center Director, Community Outreach and Engagement and Founding Director of Center of Community Alliance for Research and Education. Her focus is directed at understanding how social disparities impact heath and patient centered outcomes with the goal of developing strategies to improve quality of life and reduce health inequities.
Dr. Ashing, Professor at the Department of Population Sciences, is the Deputy Director of the Division of Health Equities, Associate Cancer Center Director, Community Outreach and Engagement and Founding Director of Center of Community Alliance for Research and Education. Her focus is directed at understanding how social disparities impact heath and patient centered outcomes with the goal of developing strategies to improve quality of life and reduce health inequities.
Andrea Bild, Ph.D.
Dr. Bild, Professor at the Department of Molecular Pharmacology, Department of Medical Oncology & Therapeutics Research, received her Ph.D. from University of Colorado, Denver. Her research team uses large-scale translational genomic and pharmacological studies to interrogate and treat tumor heterogeneity and evolution to refractory states.
Dr. Bild, Professor at the Department of Molecular Pharmacology, Department of Medical Oncology & Therapeutics Research, received her Ph.D. from University of Colorado, Denver. Her research team uses large-scale translational genomic and pharmacological studies to interrogate and treat tumor heterogeneity and evolution to refractory states.
Wing-Chun (John) Chan, M.D.
Dr. Chan, Dr. Norman and Melinda Payson Professor in Hematologic Cancer, received his M.D. from University of Hong Kong. Dr. Chan's research focuses on using genomics approaches to explore the molecular pathogenesis and classification of lymphoma. He has identified molecular signature to improve diagnosis, outcome prediction & treatment response for lymphoma patients.
Dr. Chan, Dr. Norman and Melinda Payson Professor in Hematologic Cancer, received his M.D. from University of Hong Kong. Dr. Chan's research focuses on using genomics approaches to explore the molecular pathogenesis and classification of lymphoma. He has identified molecular signature to improve diagnosis, outcome prediction & treatment response for lymphoma patients.
Shiuan Chen, Ph.D.
Dr. Chen, Lester M. and Irene C. Finkelstein Chair in Biology; Professor and Chair, Department of Cancer Biology and Molecular Medicine, received his Ph.D. from University of Hawaii. His team focuses on refining current treatment strategies and available drugs for better application against breast cancer. He also investigates how environmental chemicals and diet modulate the development of hormone-dependent cancers.
Dr. Chen, Lester M. and Irene C. Finkelstein Chair in Biology; Professor and Chair, Department of Cancer Biology and Molecular Medicine, received his Ph.D. from University of Hawaii. His team focuses on refining current treatment strategies and available drugs for better application against breast cancer. He also investigates how environmental chemicals and diet modulate the development of hormone-dependent cancers.
Betty Ferrell, Ph.D.
Dr. Ferrell, Director and Professor at the Division of Nursing Research and Education and the Department of Population Sciences, received her Ph.D. from Texas Woman’s University. Dr. Ferrell is interested in examining quality of life, pain management and palliative care for cancer patients.
Dr. Ferrell, Director and Professor at the Division of Nursing Research and Education and the Department of Population Sciences, received her Ph.D. from Texas Woman’s University. Dr. Ferrell is interested in examining quality of life, pain management and palliative care for cancer patients.
Stacy Gray, M.D.
Dr. Gray, Deputy Director, Center for Precision Medicine; Physician, Associate Professor and Chief, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, Associate Professor, Department of Population Sciences, received her M.D. from University of Chicago. Dr. Gray focuses her research on understanding the psychological effects a person might experience after receiving genetic test results.
Dr. Gray, Deputy Director, Center for Precision Medicine; Physician, Associate Professor and Chief, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, Associate Professor, Department of Population Sciences, received her M.D. from University of Chicago. Dr. Gray focuses her research on understanding the psychological effects a person might experience after receiving genetic test results.
John Kaddis, Ph.D.
Dr. Kaddis, Associate Professor at the Department of Diabetes and Cancer Discovery Science, received his Ph.D. from USC. He is currently focused on developing data systems and tools to address cutting edge questions relating to type 1 diabetes.
Dr. Kaddis, Associate Professor at the Department of Diabetes and Cancer Discovery Science, received his Ph.D. from USC. He is currently focused on developing data systems and tools to address cutting edge questions relating to type 1 diabetes.
James Lacey, Ph.D., M.P.H.
Dr. Lacey, Professor and Director, Division of Health Analytics, Department of Computational and Quantitative Medicine, received his Ph.D. from University of Michigan, Ann Arbor. He is the Director of the Division of Cancer Etiology and is currently focused on developing tools to digitize the California Teachers Study database to make access and analysis more efficient.
Dr. Lacey, Professor and Director, Division of Health Analytics, Department of Computational and Quantitative Medicine, received his Ph.D. from University of Michigan, Ann Arbor. He is the Director of the Division of Cancer Etiology and is currently focused on developing tools to digitize the California Teachers Study database to make access and analysis more efficient.
Keane Lai, M.D.
Dr. Lai, Assistant Professor, Department of Cancer Biology and Molecular Medicine, received his M.D. from University of Pittsburgh. Dr. Lai is interested in defining the role that the Wnt/β-catenin signaling pathway plays in liver cancer and pancreatic cancer. His laboratory is also working toward identifying novel therapeutic targets in this pathway to combat pancreatic cancer.
Dr. Lai, Assistant Professor, Department of Cancer Biology and Molecular Medicine, received his M.D. from University of Pittsburgh. Dr. Lai is interested in defining the role that the Wnt/β-catenin signaling pathway plays in liver cancer and pancreatic cancer. His laboratory is also working toward identifying novel therapeutic targets in this pathway to combat pancreatic cancer.
Susan Neuhausen, Ph.D.
Dr. Neuhausen, Director, Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences Professor in Cancer Etiology & Outcomes Research, received her Ph.D. from University of Minnesota. Her team focuses on identifying genetic, lifestyle, and environmental factors that cause breast, ovarian and prostate cancers, and to uncover what factors are important for disease-free survival in those who develop cancer.
Dr. Neuhausen, Director, Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences Professor in Cancer Etiology & Outcomes Research, received her Ph.D. from University of Minnesota. Her team focuses on identifying genetic, lifestyle, and environmental factors that cause breast, ovarian and prostate cancers, and to uncover what factors are important for disease-free survival in those who develop cancer.
Sunita Patel, Ph.D.
Dr. Patel, Associate Clinical Professor in Population Sciences, received her Ph.D. from Alliant University. She is identifying biological & environmental factors as either risk or protective factors for neurocognitive and psychosocial sequelae in cancer patients. Her work includes behavioral interventions to improve health disparities among ethnic minority survivors of childhood cancer.
Dr. Patel, Associate Clinical Professor in Population Sciences, received her Ph.D. from Alliant University. She is identifying biological & environmental factors as either risk or protective factors for neurocognitive and psychosocial sequelae in cancer patients. Her work includes behavioral interventions to improve health disparities among ethnic minority survivors of childhood cancer.
Anne Reb, Ph.D., N.P.
Dr. Reb, Assistant Professor of Division of Nursing Research and Education and the Department of Population Sciences, received her Ph.D. from the Catholic University of America. Her research is directed at developing models of care to address areas of symptom management and cancer survivorship with particular emphasis on mind-body interventions.
Dr. Reb, Assistant Professor of Division of Nursing Research and Education and the Department of Population Sciences, received her Ph.D. from the Catholic University of America. Her research is directed at developing models of care to address areas of symptom management and cancer survivorship with particular emphasis on mind-body interventions.
Russell Rockne, Ph.D.
Dr. Rockne, Director, Division of Mathematical Oncology, Co-director, Biostatistics and Mathematical Oncology Core,Associate Professor at the Department of Computational and Quantitative Medicine, received his Ph.D. from University of Washington. His work is based upon patient-specific mathematical models of cancer growth and response to therapy, with the goal of using mathematical models to quantify and predict disease dynamics and recurrence.
Dr. Rockne, Director, Division of Mathematical Oncology, Co-director, Biostatistics and Mathematical Oncology Core,Associate Professor at the Department of Computational and Quantitative Medicine, received his Ph.D. from University of Washington. His work is based upon patient-specific mathematical models of cancer growth and response to therapy, with the goal of using mathematical models to quantify and predict disease dynamics and recurrence.
Andrei Rodin, Ph.D.
Dr. Rodin, Professor, Department of Computational and Quantitative Medicine, received his Ph.D. from University of Texas Health Science Center, Houston. He is developing data analysis methodology and software to analyze large-scale data sets with an emphasis in understanding problems in molecular evolution.
Dr. Rodin, Professor, Department of Computational and Quantitative Medicine, received his Ph.D. from University of Texas Health Science Center, Houston. He is developing data analysis methodology and software to analyze large-scale data sets with an emphasis in understanding problems in molecular evolution.
Mina Sedrak, M.D., M.S.
Dr. Sedrak, Deputy Director of Clinical Trials, Center for Cancer and Aging, Director of Aging Research in Women’s Cancers, Assistant Professor at the Department of Medical Oncology and Therapeutics Research, received his M.D. from Rush Medical College. Dr. Sedrak is focused on examining barriers to clinical trial participation for older adults with cancer as a way to improve evidence based cancer therapy for this population.
Dr. Sedrak, Deputy Director of Clinical Trials, Center for Cancer and Aging, Director of Aging Research in Women’s Cancers, Assistant Professor at the Department of Medical Oncology and Therapeutics Research, received his M.D. from Rush Medical College. Dr. Sedrak is focused on examining barriers to clinical trial participation for older adults with cancer as a way to improve evidence based cancer therapy for this population.
Victoria Seewaldt, M.D.
Dr. Seewaldt, Associate Director, Population Sciences Research, Comprehensive Cancer Center, Professor and Chair of the Department of Population Sciences, received her M.D. from UC Davis. Her research focuses on identifying signaling networks that promote breast cancer initiation with the goal of integrating novel functional imaging strategies with risk-marker to provide early detection of interval cancers.
Dr. Seewaldt, Associate Director, Population Sciences Research, Comprehensive Cancer Center, Professor and Chair of the Department of Population Sciences, received her M.D. from UC Davis. Her research focuses on identifying signaling networks that promote breast cancer initiation with the goal of integrating novel functional imaging strategies with risk-marker to provide early detection of interval cancers.
Virginia Sun, Ph.D., R.N.
Dr. Sun, Associate Professor, Division of Nursing Research and Education, Department of Population Sciences Education, received her Ph.D. from UCLA. Her research includes diet modification for bowel dysfunction in rectal cancer survivors and remote perioperative telemonitoring of patient-reported outcomes and patient-generated health data.
Dr. Sun, Associate Professor, Division of Nursing Research and Education, Department of Population Sciences Education, received her Ph.D. from UCLA. Her research includes diet modification for bowel dysfunction in rectal cancer survivors and remote perioperative telemonitoring of patient-reported outcomes and patient-generated health data.
Nagarajan Vaidehi, Ph.D.
Dr. Vaidehi, Professor and Chair of the Department of Computational and Quantitative Medicine, Associate Director for Informatics and Computational Biomedicine, Comprehensive Cancer Center, received her Ph.D. from Indian Institute of Technology. Her laboratory focuses on developing and applying computational methods to study the structure and dynamics of membrane proteins and protein-protein interactions for identifying small molecule inhibitors.
Dr. Vaidehi, Professor and Chair of the Department of Computational and Quantitative Medicine, Associate Director for Informatics and Computational Biomedicine, Comprehensive Cancer Center, received her Ph.D. from Indian Institute of Technology. Her laboratory focuses on developing and applying computational methods to study the structure and dynamics of membrane proteins and protein-protein interactions for identifying small molecule inhibitors.
F. Lennie Wong, Ph.D.
Dr. Wong, Associate Professor at the Departments of Population Sciences and Computational and Quantitative Medicine, Division of Biostatistics, Scientist, Outcomes Research, received her Ph.D. from UCLA. She uses computer modeling to address the long-term health issues that childhood cancer survivors may face.
Dr. Wong, Associate Professor at the Departments of Population Sciences and Computational and Quantitative Medicine, Division of Biostatistics, Scientist, Outcomes Research, received her Ph.D. from UCLA. She uses computer modeling to address the long-term health issues that childhood cancer survivors may face.
Lisa Yee, M.D.
Dr. Yee, Professor and Vice Chair of Research of the Department of Surgery, received her M.D. from Yale University. Her research is focused on breast cancer prevention and symptom intervention, with emphasis on dietary and nutraceutical interventions.
Dr. Yee, Professor and Vice Chair of Research of the Department of Surgery, received her M.D. from Yale University. Her research is focused on breast cancer prevention and symptom intervention, with emphasis on dietary and nutraceutical interventions.